Skip to main content
Log in

Effects of 3-Hydroxypyridine and Succinic Acid Derivatives on Monoamine Oxidase Activity In Vitro

  • MOLECULAR BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The effects of original Russian 3-hydroxypyridine and succinic acid derivatives (emoxypine, Reamberin, and Mexidol) on monoamine oxidase (MAO-A and MAO-B) activity in rat liver were studied in vitro. The study drugs used in vitro at concentrations in the pharmacokinetic range (10 9 to 10 6 M), were found to have MAO-modulating actions, the directions depending on their chemical structural properties. The isolated 3-hydroxypyridine derivative emoxypine decreased MAO-A activity by 34 – 44% and MAO-B activity by 9 – 10% (p < 0.05 in both cases). The succinic acid derivative Reamberin increased MAO-A activity by 2-3% and MAO-B activity by 14% (p < 0.05 in both cases). Mexidol, which is a derivative of both 3-hydroxypyridine and succinic acid, decreased MAO-A activity by 13% and MAO-B activity by 4% (p < 0.05 in both cases). The 2-ethyl-3-methyl-3-hydroxypyridinium cation and the succinate anion were antagonists in terms of their MAO-modulating actions. Combining these antagonist ions into the structure of Mexidol led to complete loss of the MAO-stimulating effect of the succinate part and a significant reduction in the MAO-inhibiting action of the 3-hydroxypyridine component.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V. Z. Gorkin, Amine Oxidases and their Importance in Medicine [in Russian], Meditsina, Moscow (1981), pp. 24 – 28.

    Google Scholar 

  2. V. Z. Gorkin and L. N. Ovchinnikova, Biomed. Khim., 39(4), 2 – 10 (1993).

    CAS  Google Scholar 

  3. D. E. Edmondson, Cur. Pharm. Design, 20(2), 155 – 160 (2014).

    Article  CAS  Google Scholar 

  4. J. C. Shih, J. B. Wu, and K. Chen, J. Neural. Transm., 118(7), 979 – 986 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. C. S. Wang, E. Billett, A. Borchert, H. Kuhn, et al., Cell. Mol. Life Sci., 70(4), 599 – 630 (2013).

    Article  CAS  PubMed  Google Scholar 

  6. M. S. Song, D. Matveychuk, E. M. MacKenzie, et al., Prog. Neuropsychopharmacol. Biol. Psychiatry, 44, 118 – 124 (2013).

    Article  CAS  PubMed  Google Scholar 

  7. S. K. Al-Nuaimi and E. M. MacKenzie, Am. J. Ther., 19(6), 436 – 448 (2012).

    Article  PubMed  Google Scholar 

  8. I. A. Volchegorskii, M. G. Moskvicheva, and E. N. Chashchina, Ter. Arkhiv, 77(10), 10 – 15 (2005).

    CAS  Google Scholar 

  9. I. A. Volchegorskii and K. M. Mester, Zh. Nevrol. Psikhiat. im. S. S. Korsakova, 3, 19 – 24 (2010).

    Google Scholar 

  10. V. P. Galenko-Yarosheskii, O. N. Gulevskaya, A. V. Zelenskaya, et al., Novye Tekhnol., 2, 166 – 171 (2011).

    Google Scholar 

  11. I. A. Volchegorskii, L. M. Rassokhina, I. Yu. Miroshnichenko, et al., Byull. Éksperim. Biol. Med., 150(9), 295 – 301 (2010).

    Google Scholar 

  12. I. A. Volchegorskii, I. I. Dolgushin, O. L. Kolesnikov, and V. E. Tseilikman, Experimental Modeling and Laboratory Evaluation of the Adaptive Reactions of the Body [in Russian], Chelyabinsk Sate Pedagogical University Press, Chelyabinsk (2000), pp. 52 – 59.

    Google Scholar 

  13. I. A. Volchegorskii, N. A. Skobeleva, and R. I. Lifshits, Vopr. Med. Khim., 37(1), 86 – 89 (1991).

    CAS  PubMed  Google Scholar 

  14. K. F. Tipton, G. Davey, and M. Motherway, Curr. Protoc. Toxicol., Supplement. 30, UNIT 4.21, 4.21.1-4.21.42 (2006).

  15. E. Siewens and A. D’Iorio, Canad. J. Biochem., 48(6), 659 – 663 (1970).

    Article  Google Scholar 

  16. V. N. Orekhovich, Contemporary Methods in Biochemistry [in Russian], Meditsina, Moscow (1977), pp. 19 – 21.

    Google Scholar 

  17. I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., Éksperim. Klin. Farmakol., 76(7), 6 – 10 (2013).

    CAS  Google Scholar 

  18. L. M. Rassokhina, Doctoral Dissertation in Medical Sciences [in Russian], Moscow (2015).

  19. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, Éksperim. Klin. Farmakol., 74(12), 27 – 32 (2011).

    CAS  Google Scholar 

  20. N. Singh, J. Hroudova, and Z. Fišar, Mol. Neurobiol., September, 1 – 11 (2016).

  21. I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., Éksperim. Klin. Farmakol., 77(5), 6 – 9 (2014).

    CAS  Google Scholar 

  22. I. A. Volchegorskii, E. V. Pravdin, and T. V. Uzlova, Éksperim. Klin. Farmakol, 75(11), 22 – 27 (2012).

    CAS  Google Scholar 

  23. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, Probl. Éndokrinol., 2, 27 – 35 (2010).

    Article  Google Scholar 

  24. D. E. Kemp, F. Ismail-Beigi, S. J. Ganocy, et al., J. Affect. Disord., 136(3), 1164 – 1173 (2012).

    Article  CAS  PubMed  Google Scholar 

  25. A. L. Markowska, M. Mooney, and W. E. Sonntag, Neuroscience, 87(3), 559 – 569 (1998).

    Article  CAS  PubMed  Google Scholar 

  26. N. Morin, V. Visentin, D. Calise, et al., J. Pharmacol. Experim. Ther., 303(3), 1238 – 1247 (2002).

    Article  CAS  Google Scholar 

  27. S. V. Okovityi, S. V. Rad’ko, and E. B. Shustov, Khim.-Farm. Zh., 49(9), 3 – 7 (2015); Pharm. Chem. J., 49(9), 573 – 577 (2015).

  28. V. P. Zherdev, A. K. Sariev, A. A. Dvoryaninov, et al., Byull. Éksperim. Biol. Med., 3, 325 – 327 (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. A. Volchegorskii.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 1, pp. 3 – 7, January, 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Volchegorskii, I.A., Sinitskii, A.I., Miroshnichenko, I.Y. et al. Effects of 3-Hydroxypyridine and Succinic Acid Derivatives on Monoamine Oxidase Activity In Vitro. Pharm Chem J 52, 26–29 (2018). https://doi.org/10.1007/s11094-018-1760-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-018-1760-2

Keywords

Navigation